Dawnrays Pharmaceutical (Holdings) Balance Sheet Health
Financial Health criteria checks 6/6
Dawnrays Pharmaceutical (Holdings) has a total shareholder equity of CN¥3.3B and total debt of CN¥182.6M, which brings its debt-to-equity ratio to 5.6%. Its total assets and total liabilities are CN¥4.0B and CN¥773.4M respectively. Dawnrays Pharmaceutical (Holdings)'s EBIT is CN¥229.0M making its interest coverage ratio -8.1. It has cash and short-term investments of CN¥1.7B.
Key information
5.6%
Debt to equity ratio
CN¥182.55m
Debt
| Interest coverage ratio | -8.1x |
| Cash | CN¥1.69b |
| Equity | CN¥3.27b |
| Total liabilities | CN¥773.44m |
| Total assets | CN¥4.04b |
Recent financial health updates
Recent updates
Dawnrays Pharmaceutical (Holdings)'s (HKG:2348) Earnings Might Not Be As Promising As They Seem
Sep 21
Dawnrays Pharmaceutical (Holdings)'s (HKG:2348) Dividend Will Be CN¥0.015
Sep 11Dawnrays Pharmaceutical (Holdings)'s (HKG:2348) Dividend Will Be CN¥0.065
May 25Dawnrays Pharmaceutical (Holdings) (HKG:2348) Will Pay A Dividend Of CN¥0.065
Apr 22Dawnrays Pharmaceutical (Holdings) (HKG:2348) Has Announced A Dividend Of CN¥0.065
Apr 08Dawnrays Pharmaceutical (Holdings) (HKG:2348) Is Due To Pay A Dividend Of CN¥0.065
Mar 25Dawnrays Pharmaceutical (Holdings) (HKG:2348) Has Announced A Dividend Of CN¥0.015
Aug 30Dawnrays Pharmaceutical (Holdings)'s (HKG:2348) Shareholders Will Receive A Bigger Dividend Than Last Year
May 26Dawnrays Pharmaceutical (Holdings) (HKG:2348) Will Pay A Dividend Of CN¥0.073
Apr 04Dawnrays Pharmaceutical (Holdings)'s (HKG:2348) Dividend Will Be CN¥0.015
Sep 19Dawnrays Pharmaceutical (Holdings)'s (HKG:2348) Solid Profits Have Weak Fundamentals
Sep 22Dawnrays Pharmaceutical (Holdings) (HKG:2348) Will Pay A Dividend Of HK$0.015
Sep 12Dawnrays Pharmaceutical (Holdings)'s (HKG:2348) Dividend Will Be HK$0.015
Aug 29Here's How We Evaluate Dawnrays Pharmaceutical (Holdings) Limited's (HKG:2348) Dividend
Feb 28Would Shareholders Who Purchased Dawnrays Pharmaceutical (Holdings)'s (HKG:2348) Stock Five Years Be Happy With The Share price Today?
Feb 07
Yung Lai Hung Is The Co-Founder & Executive Director of Dawnrays Pharmaceutical (Holdings) Limited (HKG:2348) And They Just Picked Up 34% More Shares
Jan 14Dawnrays Pharmaceutical (Holdings) Limited's (HKG:2348) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?
Dec 22What Kind Of Investors Own Most Of Dawnrays Pharmaceutical (Holdings) Limited (HKG:2348)?
Dec 09Three Things You Should Check Before Buying Dawnrays Pharmaceutical (Holdings) Limited (HKG:2348) For Its Dividend
Nov 23Financial Position Analysis
Short Term Liabilities: 2348's short term assets (CN¥2.2B) exceed its short term liabilities (CN¥655.9M).
Long Term Liabilities: 2348's short term assets (CN¥2.2B) exceed its long term liabilities (CN¥117.6M).
Debt to Equity History and Analysis
Debt Level: 2348 has more cash than its total debt.
Reducing Debt: 2348's debt to equity ratio has reduced from 10% to 5.6% over the past 5 years.
Debt Coverage: 2348's debt is well covered by operating cash flow (173.9%).
Interest Coverage: 2348 earns more interest than it pays, so coverage of interest payments is not a concern.